![Jens Eckstein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jens Eckstein
Vorstandsvorsitzender bei
Samsara Therapeutics, Inc.
Vermögen: 18 037 $ am 30.09.2026
Profil
Jens W.
Eckstein currently works at Samsara Therapeutics, Inc., as Chairman & Chief Executive Officer, Aeovian Pharmaceuticals, Inc., as Director, Cleara Biotech BV, as Director from 2022, HAYA Therapeutics SA, as Director, and Apollo Ventures Holding GmbH, as Managing Partner from 2019.
Dr. Eckstein also formerly worked at SelectX Pharmaceuticals, Inc., as President & Chief Executive Officer in 2011, PPD Dermatology LLC, as Director, Concert Pharmaceuticals, Inc., as Director, Rapid Micro Biosystems, Inc., as Director, Alios BioPharma, Inc., as Director, Anchor Therapeutics, Inc., as Director, Enanta Pharmaceuticals, Inc., as Director, Thrasos Therapeutics, Inc., as Director, Biohealth Innovation, Inc., as Director, Action Potential Venture Capital, as Director from 2013 to 2019, ZappRx, Inc., as Director, Gladius Pharmaceuticals Corp., as Director, Decibel Therapeutics, Inc., as Director, Palleon Pharmaceuticals, Inc., as Director, Imugene Ltd., as Independent Non-Executive Director from 2019 to 2024, Sirtris Pharmaceuticals, Inc., as Advisor, GSK Equity Investments Ltd., as President, GPC Biotech, Inc., as Principal from 1993 to 2003, and TVM Capital Corp., as Venture Partner.
Dr. Eckstein received his doctorate degree from Harvard University and doctorate degree from Universität Konstanz.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMUGENE LTD 0,11 % | 30.06.2025 | 617.297 ( 0,11 % ) | 18 037 $ | 30.09.2026 |
Aktive Positionen von Jens Eckstein
| Unternehmen | Position | Beginn |
|---|---|---|
Samsara Therapeutics, Inc.
 Samsara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes first-in-class therapeutics for the treatment of unmet medical needs and age-related diseases | Vorstandsvorsitzender | - |
Aeovian Pharmaceuticals, Inc.
 Aeovian Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that develops small molecules | Direktor/Vorstandsmitglied | - |
Cleara Biotech BV
 Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Direktor/Vorstandsmitglied | 27.09.2022 |
Apollo Ventures Holding GmbH
 Apollo Ventures Holding GmbH Investment ManagersFinance Apollo Health Ventures invests in companies located in the Germany. | Private Equity Investor | 01.06.2019 |
HAYA Therapeutics SA
 HAYA Therapeutics SA BiotechnologyHealth Technology Develops RNA-based therapeutics to treating fibrotic diseases | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jens Eckstein
| Unternehmen | Position | Ende |
|---|---|---|
| IMUGENE LIMITED | Direktor/Vorstandsmitglied | 14.11.2024 |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Präsident | 01.07.2019 |
Action Potential Venture Capital
 Action Potential Venture Capital Investment ManagersFinance Action Potential Venture invests in companies across the globe. The firm targets companies operating in the fields of biomedical and medical technology. It provides financing for early stage capital requirements. | Direktor/Vorstandsmitglied | 01.05.2019 |
Gladius Pharmaceuticals Corp.
 Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Operates as biotechnology firm | Direktor/Vorstandsmitglied | 01.04.2019 |
| ░░░ ░░░░░░░ ░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
Ausbildung von Jens Eckstein
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
43
Beziehungen ersten Grades
26
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 26 |
|---|---|
Sirtris Pharmaceuticals, Inc.
 Sirtris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs and pharmaceuticals | Health Technology |
PPD Dermatology LLC
 PPD Dermatology LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
Rapid Micro Biosystems, Inc.
 Rapid Micro Biosystems, Inc. Industrial MachineryProducer Manufacturing Develops automation solutions for pharmaceutical and healthcare manufacturing products | Producer Manufacturing |
Alios BioPharma, Inc.
 Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases | Health Technology |
Anchor Therapeutics, Inc.
 Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Designs and develops peptide modulators of G protein-coupled receptors | Health Technology |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade Develops anticancer drugs | Retail Trade |
Enanta Pharmaceuticals, Inc.
 Enanta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs for the treatment of viral infections and liver diseases | Health Technology |
SelectX Pharmaceuticals, Inc.
 SelectX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops aminoglycoside therapeutics | Health Technology |
Universität Konstanz
 Universität Konstanz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TVM Capital Corp.
 TVM Capital Corp. Investment ManagersFinance TVM Capital invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in earlystage capital requirements. | Finance |
Thrasos Therapeutics, Inc.
 Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotheraputics for the treatment and prevention of kidney diseases | Health Technology |
Biohealth Innovation, Inc.
 Biohealth Innovation, Inc. Financial ConglomeratesFinance Sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth | Finance |
Action Potential Venture Capital
Action Potential Venture Capital Investment ManagersFinance Action Potential Venture invests in companies across the globe. The firm targets companies operating in the fields of biomedical and medical technology. It provides financing for early stage capital requirements. | Finance |
ZappRx, Inc.
 ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services Offers communication related services to pharmaceutical & healthcare providers | Commercial Services |
Gladius Pharmaceuticals Corp.
Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Operates as biotechnology firm | Health Technology |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Apollo Ventures Holding GmbH
Apollo Ventures Holding GmbH Investment ManagersFinance Apollo Health Ventures invests in companies located in the Germany. | Finance |
Aeovian Pharmaceuticals, Inc.
Aeovian Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that develops small molecules | Commercial Services |
Palleon Pharmaceuticals, Inc.
 Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Health Technology |
Samsara Therapeutics, Inc.
Samsara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes first-in-class therapeutics for the treatment of unmet medical needs and age-related diseases | Health Technology |
Cleara Biotech BV
Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
HAYA Therapeutics SA
HAYA Therapeutics SA BiotechnologyHealth Technology Develops RNA-based therapeutics to treating fibrotic diseases | Health Technology |
